SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-058320
Filing Date
2018-11-13
Accepted
2018-11-13 17:13:07
Documents
2
Period of Report
2018-11-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3611
2 POA DOCUMENT poa.txt EX-24.3_816866 3044
  Complete submission text file 0001209191-18-058320.txt   8019
Mailing Address C/O IMPRIMIS PHARMACEUTICALS, INC 12264 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130
Business Address
BAUM MARK L (Reporting) CIK: 0001274282 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38738 | Film No.: 181179049

Mailing Address 12264 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SAN DIEGO CA 92130 858-704-4040
Eton Pharmaceuticals, Inc. (Issuer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations